mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-09 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-08 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-08 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-08 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-08 |